Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.7741
-0.0030 (-0.39%)
At close: Nov 3, 2026, 4:00 PM EST
0.7949
+0.0208 (2.69%)
After-hours: Nov 3, 2026, 7:54 PM EST

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $48.75 million. The enterprise value is $17.86 million.

Market Cap48.75M
Enterprise Value 17.86M

Important Dates

The next estimated earnings date is Monday, November 16, 2026, before market open.

Earnings Date Nov 16, 2026
Ex-Dividend Date n/a

Share Statistics

CNTB has 62.97 million shares outstanding. The number of shares has increased by 4.44% in one year.

Current Share Class 62.97M
Shares Outstanding 62.97M
Shares Change (YoY) +4.44%
Shares Change (QoQ) +11.21%
Owned by Insiders (%) 15.19%
Owned by Institutions (%) 19.34%
Float 17.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 16.67
Forward PS 6.35
PB Ratio 1.82
P/TBV Ratio 1.84
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 6.21
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.02.

Current Ratio 2.37
Quick Ratio 2.11
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -140.51% and return on invested capital (ROIC) is -88.31%.

Return on Equity (ROE) -140.51%
Return on Assets (ROA) -69.75%
Return on Invested Capital (ROIC) -88.31%
Return on Capital Employed (ROCE) -259.15%
Weighted Average Cost of Capital (WACC) 3.20%
Revenue Per Employee $46,141
Profits Per Employee -$1.08M
Employee Count64
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

In the past 12 months, CNTB has paid $196,000 in taxes.

Income Tax 196,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -54.73% in the last 52 weeks. The beta is -0.18, so CNTB's price volatility has been lower than the market average.

Beta (5Y) -0.18
52-Week Price Change -54.73%
50-Day Moving Average 1.30
200-Day Moving Average 2.18
Relative Strength Index (RSI) 31.38
Average Volume (20 Days) 1,025,296

Short Selling Information

The latest short interest is 3.86 million, so 8.69% of the outstanding shares have been sold short.

Short Interest 3.86M
Short Previous Month 3.50M
Short % of Shares Out 8.69%
Short % of Float n/a
Short Ratio (days to cover) 0.41

Income Statement

In the last 12 months, CNTB had revenue of $2.95 million and -$68.99 million in losses. Loss per share was -$1.19.

Revenue2.95M
Gross Profit 2.95M
Operating Income -70.41M
Pretax Income -68.80M
Net Income -68.99M
EBITDA -69.73M
EBIT -70.41M
Loss Per Share -$1.19
Full Income Statement

Balance Sheet

The company has $31.49 million in cash and $596,000 in debt, with a net cash position of $30.89 million or $0.49 per share.

Cash & Cash Equivalents 31.49M
Total Debt 596,000
Net Cash 30.89M
Net Cash Per Share $0.49
Equity (Book Value) 26.86M
Book Value Per Share 0.43
Working Capital 22.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$60.58 million and capital expenditures -$50,000, giving a free cash flow of -$60.63 million.

Operating Cash Flow -60.58M
Capital Expenditures -50,000
Depreciation & Amortization 685,000
Net Borrowing n/a
Free Cash Flow -60.63M
FCF Per Share -$0.96
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -2,384.49%
Pretax Margin -2,329.66%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -4.44%
Shareholder Yield -4.44%
Earnings Yield -154.16%
FCF Yield -123.14%

Analyst Forecast

The average price target for CNTB is $6.00, which is 675.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.00
Price Target Difference 675.09%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (3Y) 487.12%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CNTB has an Altman Z-Score of -13.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -13.9
Piotroski F-Score 2